Pay in 4 interest-free payments of $6.01 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
The named individuals were not compensated for their help
Now that name-brand medications are more widely available, the need for compounded versions is significantly reduced
Novo Nordisk's head of US operations, James Millar, said the list price reductions are "the best approach to address the unprecedented opportunity to help more than 100 million people living with obesity and over 35 million people with type 2 diabetes in the US." He went on to say that "private and public payers, as well as patients, want access and have been calling for lower list prices." It is estimated that around one in eight people in the US were taking incretin medicines for weight loss in 2025, according to KFF Health
In essence, GLP-1 Injections help balance blood sugar levels and curb excessive cravings, guiding the body toward healthier habits
It doesnt matter what industry youre in
Both affect GLP-1 receptors, but tirzepatide also targets GIP receptors, creating a dual-action effect
US$ 26.79
US$ 22.60
US$ 22.24
US$ 29.07
